GE HealthCare Technologies (GEHC) Shares Outstanding (Diluted Average) (2022 - 2026)
GE HealthCare Technologies (GEHC) reported Shares Outstanding (Diluted Average) of $457.0 million for Q1 2026, little changed on a YoY basis from $459.0 million in Q1 2025, and little changed quarter-over-quarter from $458.0 million in Q4 2025.
GE HealthCare Technologies (GEHC) Shares Outstanding (Diluted Average) (2022 - 2026) Analysis & Trends
GE HealthCare Technologies has reported Shares Outstanding (Diluted Average) for 5 years, with the latest figure at $457.0 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) changed 0.44% year-over-year to $457.0 million; the trailing twelve-month figure through Mar 2026 stood at $457.0 million (changed 0.44% YoY), and the FY2025 full-year result was $458.0 million, changed 0.22% from the prior year.
- Shares Outstanding (Diluted Average) for Q1 2026 stood at $457.0 million, roughly flat from $458.0 million in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $459.0 million in Q1 2024, with the low at $454.0 million in Q1 2022.
- Historically, Shares Outstanding (Diluted Average) has averaged $457.2 million across 5 years, with a median of $458.0 million in 2023.
- Annual changes were most pronounced in 2023 — Shares Outstanding (Diluted Average) gained 0.88% — and 2025, when it fell 0.44%.
- GE HealthCare Technologies' Shares Outstanding (Diluted Average) stood at $454.0 million in 2022, then gained by 0.88% to $458.0 million in 2023, then increased by 0.22% to $459.0 million in 2024, then fell by 0.22% to $458.0 million in 2025, then declined by 0.22% to $457.0 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $457.0 million (Q1 2026), $458.0 million (Q4 2025), and $457.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 457.00 Mn |
| Dec 31, 2025 | 458.00 Mn |
| Sep 30, 2025 | 457.00 Mn |
| Jun 30, 2025 | 458.00 Mn |
| Mar 31, 2025 | 459.00 Mn |
| Dec 31, 2024 | 459.00 Mn |
| Sep 30, 2024 | 459.00 Mn |
| Jun 30, 2024 | 459.00 Mn |
| Mar 31, 2024 | 459.00 Mn |
| Dec 31, 2023 | 458.00 Mn |
| Sep 30, 2023 | 458.00 Mn |
| Jun 30, 2023 | 458.00 Mn |
| Mar 31, 2023 | 457.00 Mn |
| Dec 31, 2022 | 454.00 Mn |
| Sep 30, 2022 | 454.00 Mn |
| Jun 30, 2022 | 454.00 Mn |
| Mar 31, 2022 | 454.00 Mn |